The latest report published by IMARC Group, titled “Sleep Apnea Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global sleep apnea devices market size reached US$ 7.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.5 Billion by 2027, exhibiting a growth rate (CAGR) of 7.07% during 2022-2027.
Market Growth Drivers:
Continuous improvements in healthcare infrastructures and the expanding geriatric population, who are more susceptible to developing hypertension, diabetes, cardiovascular diseases (CVDs), etc., are primarily augmenting the sleep apnea devices market. Furthermore, the growing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea, and complex sleep apnea syndrome is positively influencing the global market.
Apart from this, the rising consumer awareness towards the prolonged effects of sleep apnea is acting as another significant growth-inducing factor. Moreover, several product innovations, including the introduction of out-of-center (OOC) testing devices that examine cardiovascular, oximetry, and respiratory parameters, as well as sleep patterns, for the diagnosis of OSA, are bolstering the market growth. Besides this, the miniaturization and the development of affordable devices by various brands are expected to fuel the sleep apnea devices market in the coming years.
Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/sleep-apnea-devices-market/requestsample
Market Insight:
Sleep apnea, or sleep-disordered breathing (SDB), refers to an acute medical condition in which the oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Some of the commonly available sleep apnea diagnostic and therapeutic devices include bilevel positive airway pressure (BiPAP), continuous positive airway pressure (CPAP), and variable positive airway pressure (VPAP) machines. They are used to evaluate the patient respiratory and other bodily functions during sleep. In addition to this, numerous oral devices, such as the mandibular advancement device (MAD) and tongue retaining device, are also utilized for treating mild to moderate cases of sleep apnea.
Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global sleep apnea devices market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Players Included in Market Research Report:
- BMC Medical Co. (SHE: 301367)
- Braebon Medical Corporation
- Cadwell Laboratories Inc.
- CareFusion Corp.
- Curative Medical Inc.
- Devilbiss Healthcare
- Fisher & Paykel Healthcare (OTCMKTS: FSPKF)
- GE Healthcare (NYSE: GE)
- Invacare (NYSE: IVC)
- Oventus Medical
- Panthera Dental
- ResMed (NYSE: RMD)
- Somnomed Ltd. (ASX: SOM)
- Vyaire Medical Inc.
- Whole You Inc.
Market Segmentation:
The report has segmented the global sleep apnea devices market on the basis of product type, end-user and region.
Based on Product Type:
- Therapeutic Devices
- Diagnostic Devices
Based on End-User:
- Hospitals and Clinics
- Sleep Laboratories
- Homecare Settings
- Others
Geographical Analysis:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=1863&flag=C
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
